39
Participants
Start Date
May 6, 2009
Primary Completion Date
October 7, 2018
Study Completion Date
October 7, 2018
Lenalidomide
Starting dose 5 mg by mouth every other day; increase to 5 mg/d daily in 4-5 weeks for 6 - 12 months
Fludarabine
30 mg/m\^2 intravenously daily on days -5, -4, -3.
Rituximab
375 mg/m2 intravenously on day -13, and 1000 mg/m\^2 on days -6, +1 and +8.
Thymoglobulin
1.0 mg/kg intravenously over 4 hours (day -2 and -1).
Stem Cell Transplantation
On Day 0, donor blood stem cells collected will be transplanted over 30-45 minutes.
Bendamustine
130 mg/m2/day by vein daily on day -5, -4, -3 (following Fludarabine).
Allopurinol
300 mg by mouth daily beginning at the start of lenalidomide therapy and continuing for 3 months.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER